• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神障碍多基因风险评分:儿童和青少年精神科医生的知识、态度和经验。

Psychiatric polygenic risk scores: Child and adolescent psychiatrists' knowledge, attitudes, and experiences.

机构信息

Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, USA.

School of Medicine, Emory University, Atlanta, Georgia, USA.

出版信息

Am J Med Genet B Neuropsychiatr Genet. 2022 Oct;189(7-8):293-302. doi: 10.1002/ajmg.b.32912. Epub 2022 Jul 6.

DOI:10.1002/ajmg.b.32912
PMID:35792502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9444963/
Abstract

Psychiatric polygenic risk scores (PRS) have potential utility in psychiatric care and prevention, but there are concerns about their implementation. We surveyed 960 US-based practicing child and adolescent psychiatrists' (CAP) about their experiences, perspectives, and potential uses of psychiatric PRS. While 23% of CAP reported that they had never heard of PRS, 10 % of respondents have had a patient/family bring PRS to them and 4% have generated PRS for patients. Though 25% stated they would request PRS if a patient/caregiver asked, 35% indicated that nothing would prompt them to request PRS. Most respondents (54%) believed psychiatric PRS are currently at least slightly useful and 87% believed they will be so in 5 years. More than 70% indicated they would take action in response to a child with a top fifth percentile psychiatric PRS but no diagnosis: 48% would increase monitoring of symptoms, 42% would evaluate for current symptoms, and 4% would prescribe medications. Yet, most respondents were concerned that high-PRS results could lead to overtreatment and negatively impact patients' emotional well-being. Findings indicate emerging use of psychiatric PRS within child and adolescent psychiatry in the US. It is critical to examine the ethical and clinical challenges that PRS may generate and begin efforts to promote their informed and responsible use.

摘要

精神科多基因风险评分(PRS)在精神科护理和预防方面具有潜在的应用价值,但人们对其实施存在一些担忧。我们调查了 960 名美国执业儿童和青少年精神科医生(CAP),了解他们在精神科 PRS 方面的经验、观点和潜在用途。虽然 23%的 CAP 报告称他们从未听说过 PRS,但有 10%的受访者曾有患者/家属向他们提及 PRS,4%的受访者曾为患者生成 PRS。尽管 25%的受访者表示如果患者/照顾者提出要求,他们会要求 PRS,但 35%的受访者表示没有任何因素会促使他们要求 PRS。大多数受访者(54%)认为精神科 PRS 目前至少有一定的用处,87%的受访者认为 5 年后会如此。超过 70%的受访者表示,他们会对 PRS 排名在前五分之一但没有诊断的儿童采取行动:48%的人会增加对症状的监测,42%的人会评估当前症状,4%的人会开处方。然而,大多数受访者担心高 PRS 结果可能导致过度治疗,并对患者的情绪健康产生负面影响。研究结果表明,精神科 PRS 在美国儿童和青少年精神科领域的应用正在兴起。重要的是要检查 PRS 可能产生的伦理和临床挑战,并开始努力促进其知情和负责任的使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/9444963/f021e75217fa/nihms-1822396-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/9444963/fb03042dc168/nihms-1822396-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/9444963/a98dfa1530d9/nihms-1822396-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/9444963/789d30dca727/nihms-1822396-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/9444963/f021e75217fa/nihms-1822396-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/9444963/fb03042dc168/nihms-1822396-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/9444963/a98dfa1530d9/nihms-1822396-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/9444963/789d30dca727/nihms-1822396-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/9444963/f021e75217fa/nihms-1822396-f0004.jpg

相似文献

1
Psychiatric polygenic risk scores: Child and adolescent psychiatrists' knowledge, attitudes, and experiences.精神障碍多基因风险评分:儿童和青少年精神科医生的知识、态度和经验。
Am J Med Genet B Neuropsychiatr Genet. 2022 Oct;189(7-8):293-302. doi: 10.1002/ajmg.b.32912. Epub 2022 Jul 6.
2
Psychiatric polygenic risk scores: Experience, hope for utility, and concerns among child and adolescent psychiatrists.精神疾病多基因风险评分:儿童和青少年精神科医生的经验、对其应用的希望和担忧。
Psychiatry Res. 2024 Sep;339:116080. doi: 10.1016/j.psychres.2024.116080. Epub 2024 Jul 7.
3
Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice.儿童和青少年精神科医生在临床实践中对基因检测和药物遗传学的使用、态度和理解。
Psychiatry Res. 2023 Jul;325:115246. doi: 10.1016/j.psychres.2023.115246. Epub 2023 May 6.
4
How do experts in psychiatric genetics view the clinical utility of polygenic risk scores for schizophrenia?精神遗传学专家如何看待精神分裂症多基因风险评分的临床实用性?
Am J Med Genet B Neuropsychiatr Genet. 2023 Oct-Dec;192(7-8):161-170. doi: 10.1002/ajmg.b.32939. Epub 2023 May 9.
5
Could Polygenic Risk Scores Be Useful in Psychiatry?: A Review.多基因风险评分在精神病学中的应用价值:综述。
JAMA Psychiatry. 2021 Feb 1;78(2):210-219. doi: 10.1001/jamapsychiatry.2020.3042.
6
Child and Adolescent Psychiatrists' Use, Attitudes, and Understanding of Genetic Tests in Clinical Practice.儿童和青少年精神科医生在临床实践中对基因检测的使用、态度及理解
medRxiv. 2023 Jan 28:2023.01.24.23284953. doi: 10.1101/2023.01.24.23284953.
7
Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.精神科医生对精神分裂症患者代谢不良事件的态度。
PLoS One. 2014 Jan 23;9(1):e86826. doi: 10.1371/journal.pone.0086826. eCollection 2014.
8
Psychiatrists' knowledge and attitudes about costs of commonly prescribed treatments in psychiatry.精神科医生对精神科常用治疗费用的了解与态度。
J Community Health. 2001 Feb;26(1):11-22. doi: 10.1023/a:1026533013729.
9
Child and adolescent psychiatrists' attitudes and practices prescribing second generation antipsychotics.儿童和青少年精神科医生在开具第二代抗精神病药物方面的态度和做法。
J Child Adolesc Psychopharmacol. 2014 Mar;24(2):90-3. doi: 10.1089/cap.2013.0133.
10
Evidence-based psychiatry--do psychiatrists want it and can they do it?循证精神病学——精神科医生想要它吗?他们能做到吗?
Health Bull (Edinb). 2000 Jan;58(1):25-33.

引用本文的文献

1
Preimplantation genetic testing for polygenic disorders: Viewpoints of reproductive genetic counselors and reproductive endocrinology and infertility specialists in the United States.多基因疾病的植入前基因检测:美国生殖遗传咨询师及生殖内分泌与不孕不育专家的观点
J Genet Couns. 2025 Jun;34(3):e70072. doi: 10.1002/jgc4.70072.
2
Review: Child Psychiatry in the Era of Genomics: The Promise of Translational Genetics Research for the Clinic.综述:基因组学时代的儿童精神病学:转化遗传学研究对临床的前景。
JAACAP Open. 2024 Aug 9;3(2):157-170. doi: 10.1016/j.jaacop.2024.06.002. eCollection 2025 Jun.
3
Ethical and social issues in prediction of risk of severe mental illness: a scoping review and thematic analysis.

本文引用的文献

1
Utility of polygenic embryo screening for disease depends on the selection strategy.多基因胚胎筛查在疾病中的效用取决于选择策略。
Elife. 2021 Oct 12;10:e64716. doi: 10.7554/eLife.64716.
2
Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results?为什么人们会寻求复杂疾病的多基因风险评分,以及他们如何理解和应对这些结果?
Eur J Hum Genet. 2022 Jan;30(1):81-87. doi: 10.1038/s41431-021-00929-3. Epub 2021 Jul 19.
3
Problems with Using Polygenic Scores to Select Embryos.使用多基因评分选择胚胎存在的问题。
严重精神疾病风险预测中的伦理和社会问题:一项范围综述与主题分析
BMC Psychiatry. 2025 May 19;25(1):501. doi: 10.1186/s12888-025-06949-3.
4
Navigating the Future of Polygenic Risk Scores: Insights from Child and Adolescent Psychiatrists.探索多基因风险评分的未来:儿童和青少年精神科医生的见解
Child Psychiatry Hum Dev. 2025 May 17. doi: 10.1007/s10578-025-01854-y.
5
Polygenic risk scores in the clinic: a systematic review of stakeholders' perspectives, attitudes, and experiences.临床中的多基因风险评分:对利益相关者观点、态度和经历的系统评价
Eur J Hum Genet. 2025 Mar;33(3):266-280. doi: 10.1038/s41431-024-01747-z. Epub 2024 Nov 23.
6
Psychiatric polygenic risk scores: Experience, hope for utility, and concerns among child and adolescent psychiatrists.精神疾病多基因风险评分:儿童和青少年精神科医生的经验、对其应用的希望和担忧。
Psychiatry Res. 2024 Sep;339:116080. doi: 10.1016/j.psychres.2024.116080. Epub 2024 Jul 7.
7
Genetics for mental health clinicians: a call for a globally accessible and equitable psychiatric genetics education.面向心理健康临床医生的遗传学:呼吁开展全球可及且公平的精神科遗传学教育。
World Psychiatry. 2024 Feb;23(1):161-163. doi: 10.1002/wps.21173.
8
Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice.儿童和青少年精神科医生在临床实践中对基因检测和药物遗传学的使用、态度和理解。
Psychiatry Res. 2023 Jul;325:115246. doi: 10.1016/j.psychres.2023.115246. Epub 2023 May 6.
9
How do experts in psychiatric genetics view the clinical utility of polygenic risk scores for schizophrenia?精神遗传学专家如何看待精神分裂症多基因风险评分的临床实用性?
Am J Med Genet B Neuropsychiatr Genet. 2023 Oct-Dec;192(7-8):161-170. doi: 10.1002/ajmg.b.32939. Epub 2023 May 9.
N Engl J Med. 2021 Jul 1;385(1):78-86. doi: 10.1056/NEJMsr2105065.
4
Child and Adolescent Psychiatrists' Perceptions of Utility and Self-rated Knowledge of Genetic Testing Predict Usage for Autism Spectrum Disorder.儿童和青少年精神科医生对遗传检测的效用和自我评估知识的看法预测了其在自闭症谱系障碍中的使用。
J Am Acad Child Adolesc Psychiatry. 2021 Jun;60(6):657-660. doi: 10.1016/j.jaac.2021.01.022. Epub 2021 Feb 18.
5
Risk of Early-Onset Depression Associated With Polygenic Liability, Parental Psychiatric History, and Socioeconomic Status.多基因风险、父母精神病史与社会经济地位与早发性抑郁的关联。
JAMA Psychiatry. 2021 Apr 1;78(4):387-397. doi: 10.1001/jamapsychiatry.2020.4172.
6
Screening embryos for polygenic conditions and traits: ethical considerations for an emerging technology.对胚胎进行多基因疾病和性状筛查:一项新兴技术的伦理考量
Genet Med. 2021 Mar;23(3):432-434. doi: 10.1038/s41436-020-01019-3. Epub 2020 Oct 27.
7
Could Polygenic Risk Scores Be Useful in Psychiatry?: A Review.多基因风险评分在精神病学中的应用价值:综述。
JAMA Psychiatry. 2021 Feb 1;78(2):210-219. doi: 10.1001/jamapsychiatry.2020.3042.
8
Return of results in a global survey of psychiatric genetics researchers: practices, attitudes, and knowledge.全球精神遗传学研究人员调查结果的反馈:实践、态度和知识。
Genet Med. 2021 Feb;23(2):298-305. doi: 10.1038/s41436-020-00986-x. Epub 2020 Oct 9.
9
From Basic Science to Clinical Application of Polygenic Risk Scores: A Primer.从多基因风险评分的基础科学到临床应用:入门指南。
JAMA Psychiatry. 2021 Jan 1;78(1):101-109. doi: 10.1001/jamapsychiatry.2020.3049.
10
Impute.me: An Open-Source, Non-profit Tool for Using Data From Direct-to-Consumer Genetic Testing to Calculate and Interpret Polygenic Risk Scores.Impute.me:一种用于利用直接面向消费者的基因检测数据来计算和解释多基因风险评分的开源非营利工具。
Front Genet. 2020 Jun 30;11:578. doi: 10.3389/fgene.2020.00578. eCollection 2020.